QRG Capital Management Inc. grew its stake in shares of Genpact Limited (NYSE:G – Free Report) by 9.6% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The fund owned 87,583 shares of the business services provider’s stock after acquiring an additional 7,690 shares during the quarter. QRG Capital Management Inc.’s holdings in Genpact were worth $3,762,000 at the end of the most recent quarter.
Other institutional investors and hedge funds also recently modified their holdings of the company. Jensen Investment Management Inc. raised its position in shares of Genpact by 6.4% in the 3rd quarter. Jensen Investment Management Inc. now owns 189,985 shares of the business services provider’s stock worth $7,449,000 after buying an additional 11,410 shares during the period. Stifel Financial Corp purchased a new position in shares of Genpact in the 3rd quarter worth about $1,197,000. Blue Trust Inc. lifted its stake in shares of Genpact by 8.7% in the 4th quarter. Blue Trust Inc. now owns 5,531 shares of the business services provider’s stock valued at $217,000 after purchasing an additional 441 shares in the last quarter. Burney Co. grew its holdings in shares of Genpact by 242.8% during the 4th quarter. Burney Co. now owns 130,798 shares of the business services provider’s stock worth $5,618,000 after purchasing an additional 92,641 shares during the period. Finally, KBC Group NV acquired a new stake in Genpact during the 4th quarter worth approximately $298,000. Institutional investors and hedge funds own 96.03% of the company’s stock.
Genpact Trading Up 1.0 %
Shares of G opened at $53.22 on Friday. The company has a debt-to-equity ratio of 0.50, a quick ratio of 1.85 and a current ratio of 2.16. Genpact Limited has a one year low of $30.23 and a one year high of $56.76. The stock has a 50-day moving average price of $48.00 and a 200 day moving average price of $43.38. The company has a market capitalization of $9.39 billion, a P/E ratio of 18.74, a P/E/G ratio of 1.84 and a beta of 1.20.
Genpact Increases Dividend
The business also recently announced a quarterly dividend, which will be paid on Wednesday, March 26th. Stockholders of record on Tuesday, March 11th will be paid a $0.17 dividend. This represents a $0.68 dividend on an annualized basis and a dividend yield of 1.28%. The ex-dividend date of this dividend is Tuesday, March 11th. This is a positive change from Genpact’s previous quarterly dividend of $0.15. Genpact’s dividend payout ratio is 23.94%.
Insider Transactions at Genpact
In other news, SVP Piyush Mehta sold 12,000 shares of Genpact stock in a transaction dated Friday, January 10th. The shares were sold at an average price of $42.83, for a total value of $513,960.00. Following the completion of the transaction, the senior vice president now directly owns 151,182 shares of the company’s stock, valued at approximately $6,475,125.06. The trade was a 7.35 % decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, CEO Balkrishan Kalra sold 13,600 shares of the business’s stock in a transaction dated Friday, December 13th. The shares were sold at an average price of $44.60, for a total transaction of $606,560.00. Following the sale, the chief executive officer now directly owns 267,404 shares of the company’s stock, valued at approximately $11,926,218.40. This represents a 4.84 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 2.80% of the company’s stock.
Analysts Set New Price Targets
G has been the topic of a number of recent research reports. Robert W. Baird lifted their price target on shares of Genpact from $44.00 to $48.00 and gave the company a “neutral” rating in a research report on Friday, November 8th. Needham & Company LLC upped their price target on shares of Genpact from $55.00 to $65.00 and gave the stock a “buy” rating in a research report on Friday, February 7th. TD Cowen raised Genpact from a “hold” rating to a “buy” rating and raised their price objective for the company from $45.00 to $60.00 in a research report on Friday, February 7th. Jefferies Financial Group raised Genpact from a “hold” rating to a “buy” rating and upped their target price for the stock from $44.00 to $55.00 in a research report on Tuesday, January 21st. Finally, Mizuho raised their target price on Genpact from $45.00 to $55.00 and gave the company a “neutral” rating in a report on Monday, February 10th. Six equities research analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. According to data from MarketBeat, Genpact has a consensus rating of “Hold” and an average price target of $48.44.
Get Our Latest Report on Genpact
Genpact Profile
Genpact Limited provides business process outsourcing and information technology services in India, rest of Asia, North and Latin America, and Europe. It operates through three segments: Financial services; Consumer and Healthcare; and High Tech and Manufacturing. The Financial Services segment offers retail customer onboarding, customer service, collections, card servicing operations, loan and payment operations, commercial loan, equipment and auto loan, mortgage origination, compliance services, reporting and monitoring, and wealth management operations support; financial crime and risk management services; and underwriting support, new business processing, policy administration, claims management, catastrophe modeling and actuarial services, as well as property and casualty claims.
Featured Articles
- Five stocks we like better than Genpact
- P/E Ratio Calculation: How to Assess Stocks
- Autodesk Designs Value for Investors: Uptrend Set to Continue
- Options Trading – Understanding Strike Price
- Anheuser-Busch Stock Rallies—Is the King of Beers Back?
- How to Invest in Biotech Stocks
- MarketBeat Week in Review – 02/24 – 02/28
Want to see what other hedge funds are holding G? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Genpact Limited (NYSE:G – Free Report).
Receive News & Ratings for Genpact Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genpact and related companies with MarketBeat.com's FREE daily email newsletter.